Full attention: As adults become more commonly diagnosed with ADHD, industry revenue rises

The fact that ADHD is one of the most commonly diagnosed conditions for children in the United States, coupled with the fact that adults recently overtook children as the industry's largest market share, provided a boon to the ADHD Medication Manufacturing industry. Healthcare reform will enable more children to access behavioral health services, resulting in more patients being diagnosed with ADHD earlier and treated. Over the five years to 2022, industry revenue is forecast to grow. Due to the American Psychiatric Association establishing guidelines for diagnosing ADHD in adults in 2013, usage rates for ADHD drugs from adults will likely increase over the next five years...purchase to read more.

Industry Statistics & Market Size
Annual Growth 12-17
Forecast Growth 17-22
Market Share of Companies

Industry Threats & Opportunities

  • The emergence of more low-cost generic ADHD drugs has resulted in increased price competition
  • The industry has benefited from the APA’s expansion of ADHD symptoms to include more age demographics
  • Healthcare reform will provide a boon to the industry
  • Industry Report - Industry Investment Chapter

    The ADHD Medication Manufacturing industry exhibits a moderate level of capital intensity. In 2017, for every dollar spent on labor, the industry incurs an estimated $0.22 in capital expenditures, down slightly from $0.25 in 2012. Overall, industry manufacturers invest in manufacturing facilities that comply with the Food and Drug Administration's (FDA) current good manufacturing practices (CGMPs), which adds to capital expenditures. Furthermore, many ADHD drug manufacturers conduct in-house clinical trials to prove the efficacy of their drug. As a result of needing clinical trial equipment, this trend adds to capital expenditures. Comparatively, wages account for 10.0% of industry revenue. Ove...purchase to read more.

    Additional Insights for the ADHD Medication Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the ADHD Medication Manufacturing Industry are

  • Must comply with required product standards
  • Establishment of brand names
  • Fast adjustments made to changing regulations
  • IBISWorld analysts also discuss how external factors such as Federal funding for Medicare and Medicaid and Number of people with private health insurance in the ADHD Medication Manufacturing industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Federal funding for Medicare and Medicaid
  • Number of people with private health insurance
  • Number of children aged nine and younger
  • Research and development expenditure
  • Trade-weighted index

  • Current Performance
  • ADHD demographic trends
  • Healthcare reform
  • Chart: Revenue Growth

  • Industry Outlook
  • Adult ADHD boosts demand
  • Healthcare reform
  • Table: ADHD Medication Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - ADHD Medication Manufacturing Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Pharmacies & Drug Stores
  • Mental Health & Substance Abuse Clinics
  • Hospitals
  • Psychiatric Hospitals
  • Residential Intellectual Disability Facilities

  • Key Selling Industries
  • Biotechnology
  • Inorganic Chemical Manufacturing
  • Medical Instrument & Supply Manufacturing
  • Organic Chemical Manufacturing
  • Soap & Cleaning Compound Manufacturing

  • Products & Services
  • Amphetamine and dextroamphetamine medications
  • Lisdexamfetamine medications
  • Methylphenidate and dexmethylphenidate medications
  • Chart: ADHD Medication Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
    Major Markets
  • Individuals aged 18 and older
  • Children aged 12 and younger
  • Children aged 13 to 17
  • Chart: Major Market Segmentation for the ADHD Medication Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Profit
  • Purchases
  • Wages
  • Other costs
  • Chart: Cost Structure Benchmarking – Sector vs ADHD Medication Manufacturing

  • Basis of Competition
  • Internal competition
  • External competition

  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the ADHD Medication Manufacturing Industry

  • Industry Globalization
    Shire plc,
  • Table: Shire plc - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the ADHD Medication Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the ADHD Medication Manufacturing Industry
  • Industry Revenue (2008-2022)
  • Industry Gross Product (2008-2022)
  • Establishments (2008-2022)
  • Businesses (2008-2022)
  • Employment (2008-2022)
  • Exports (2008-2022)
  • Imports (2008-2022)
  • Wages (2008-2022)
  • Total health expenditure (2008-2022)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Abbreviated New Drug Application (Anda)
  • An application for the approval of a generic drug where manufacturers must scientifically prove that their products are bioequivalent to the brand products.
  • New Drug Application (Nda)
  • An application filed for the approval of a new drug product. Once approved, the product may be marketed in the United States.
  • Patent Cliff
  • The period when numerous patents on blockbuster drugs are set to expire.
  • What Our Customers Say

    Why buy this report?

    The ADHD Medication Manufacturing industry market report contains data and analysis of the most influential current and future trends shaping the industry. IBISWorld’s in-depth industry market research is presented in a logical, user-friendly format, and provides growth and profit forecasts for a five-year outlook period.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on ADHD Medication Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The ADHD Medication Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on ADHD Medication Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.